معرفی
Matthew Baxter is a Postdoctoral Researcher at the University of Oxford affiliated with the Hughes Group (Genome Biology) and Goel Group (Cardiovascular genetics and bioinformatics) within the Institute of Molecular Medicine, as evidenced by his institutional email domain matthew.baxter@imm.ox.ac.uk.
His research integrates molecular genomics, computational biology, and machine learning to decipher gene regulation mechanisms in health and disease, with primary focus on coronary artery disease. He investigates how non-coding genomic variants alter cellular phenotypes through chromosome conformation capture technologies and predictive modeling, aiming to bridge genetic associations with pathological outcomes.
Analysis of his 2022-2025 publications reveals consistent themes in cardiovascular genomics, circadian biology, and bioinformatics innovation. Key trends include development of computational tools for genetic variant analysis (CREST-GV, REnformer), exploration of circadian-immune-metabolic interactions using large-scale biobank data, and methodological advances in epigenomic sequencing pipelines.
Dr. Baxter operates within Oxford's collaborative research ecosystem through dual group affiliations: the Hughes Group advancing genome biology techniques and the Goel Group specializing in cardiovascular bioinformatics, enabling interdisciplinary approaches to complex disease mechanisms.
.jpg)
